Premium
INITIAL RESULTS OF A MULTICENTER PHASE 2 STUDY OF VENETOCLAX IN COMBINATION WITH DOSE‐ADJUSTED R‐EPOCH FOR PATIENTS WITH RICHTER'S SYNDROME (CRC‐043)
Author(s) -
Davids M.S.,
Thompson P.A.,
Rogers K.A.,
Tyekucheva S.,
Pazienza S.,
Francoeur K.,
Renner S.K.,
Bazemore J.,
Rocchio M.,
Ihuoma U.,
Jacobson C.A.,
Fisher D.C.,
Brown J.R.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.94_2629
Subject(s) - ven , medicine , venetoclax , epoch (astronomy) , lenalidomide , gastroenterology , nuclear medicine , surgery , dexamethasone , leukemia , physics , chronic lymphocytic leukemia , humanities , stars , philosophy , astronomy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom